The Role of Potassium Channels in Chronic Stress-Induced Brain Injury
Chronic stress-induced brain injury (CSBI) is the organic damage of brain tissue caused by long-term psychological and environmental stress. However, there is no effective drug for the treatment of CSBI. The present study aimed to investigate possible mechanisms of CSBI and to explore related therap...
Saved in:
| Published in | Biological & pharmaceutical bulletin Vol. 44; no. 2; pp. 169 - 180 |
|---|---|
| Main Authors | , , , , , , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
Japan
The Pharmaceutical Society of Japan
01.02.2021
Pharmaceutical Society of Japan Japan Science and Technology Agency |
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | Chronic stress-induced brain injury (CSBI) is the organic damage of brain tissue caused by long-term psychological and environmental stress. However, there is no effective drug for the treatment of CSBI. The present study aimed to investigate possible mechanisms of CSBI and to explore related therapeutic targets. A rat model of CSBI was established by combining chronic restraint and cold water immersion. Our CSBI model was validated via Nissl staining, Western blotting, and behavioral tests. RNA sequencing (RNA-seq) was used to identify differentially expressed genes (DEGs) within brain tissue during CSBI. Both Kyoto Encyclopedia of Genes and Genomes (KEGG) and Gene Ontology (GO) analyses were performed to determine signaling pathways associated with CSBI-induced DEGs. Agonists/antagonists were used to validate the pharmacodynamics of potential therapeutic targets. A combination of chronic restraint and cold water immersion successfully induced a rat model of CSBI, as indicated by various markers of brain injury and cell apoptosis that were verified via Nissl staining, Western blotting, and behavioral tests. RNA-seq analysis identified 1131 DEGs in CSBI rats. Of these DEGs, 553 genes were up-regulated and 778 genes were down-regulated. GO and KEGG pathway analyses revealed that significant DEGs were predominantly related to membrane-bound ion channels, among which the potassium channel function was found to be significantly affected. Pharmacological experiments revealed that retigabine, a voltage-gated potassium channel opener, demonstrated a protective effect in CSBI rats. Taken together, our findings suggest that potassium channel function is disrupted in CSBI, and that potassium channel regulators may function as anti-CSBI drugs. |
|---|---|
| AbstractList | Chronic stress-induced brain injury (CSBI) is the organic damage of brain tissue caused by long-term psychological and environmental stress. However, there is no effective drug for the treatment of CSBI. The present study aimed to investigate possible mechanisms of CSBI and to explore related therapeutic targets. A rat model of CSBI was established by combining chronic restraint and cold water immersion. Our CSBI model was validated via Nissl staining, Western blotting, and behavioral tests. RNA sequencing (RNA-seq) was used to identify differentially expressed genes (DEGs) within brain tissue during CSBI. Both Kyoto Encyclopedia of Genes and Genomes (KEGG) and Gene Ontology (GO) analyses were performed to determine signaling pathways associated with CSBI-induced DEGs. Agonists/antagonists were used to validate the pharmacodynamics of potential therapeutic targets. A combination of chronic restraint and cold water immersion successfully induced a rat model of CSBI, as indicated by various markers of brain injury and cell apoptosis that were verified via Nissl staining, Western blotting, and behavioral tests. RNA-seq analysis identified 1131 DEGs in CSBI rats. Of these DEGs, 553 genes were up-regulated and 778 genes were down-regulated. GO and KEGG pathway analyses revealed that significant DEGs were predominantly related to membrane-bound ion channels, among which the potassium channel function was found to be significantly affected. Pharmacological experiments revealed that retigabine, a voltage-gated potassium channel opener, demonstrated a protective effect in CSBI rats. Taken together, our findings suggest that potassium channel function is disrupted in CSBI, and that potassium channel regulators may function as anti-CSBI drugs.Chronic stress-induced brain injury (CSBI) is the organic damage of brain tissue caused by long-term psychological and environmental stress. However, there is no effective drug for the treatment of CSBI. The present study aimed to investigate possible mechanisms of CSBI and to explore related therapeutic targets. A rat model of CSBI was established by combining chronic restraint and cold water immersion. Our CSBI model was validated via Nissl staining, Western blotting, and behavioral tests. RNA sequencing (RNA-seq) was used to identify differentially expressed genes (DEGs) within brain tissue during CSBI. Both Kyoto Encyclopedia of Genes and Genomes (KEGG) and Gene Ontology (GO) analyses were performed to determine signaling pathways associated with CSBI-induced DEGs. Agonists/antagonists were used to validate the pharmacodynamics of potential therapeutic targets. A combination of chronic restraint and cold water immersion successfully induced a rat model of CSBI, as indicated by various markers of brain injury and cell apoptosis that were verified via Nissl staining, Western blotting, and behavioral tests. RNA-seq analysis identified 1131 DEGs in CSBI rats. Of these DEGs, 553 genes were up-regulated and 778 genes were down-regulated. GO and KEGG pathway analyses revealed that significant DEGs were predominantly related to membrane-bound ion channels, among which the potassium channel function was found to be significantly affected. Pharmacological experiments revealed that retigabine, a voltage-gated potassium channel opener, demonstrated a protective effect in CSBI rats. Taken together, our findings suggest that potassium channel function is disrupted in CSBI, and that potassium channel regulators may function as anti-CSBI drugs. Chronic stress-induced brain injury (CSBI) is the organic damage of brain tissue caused by long-term psychological and environmental stress. However, there is no effective drug for the treatment of CSBI. The present study aimed to investigate possible mechanisms of CSBI and to explore related therapeutic targets. A rat model of CSBI was established by combining chronic restraint and cold water immersion. Our CSBI model was validated via Nissl staining, Western blotting, and behavioral tests. RNA sequencing (RNA-seq) was used to identify differentially expressed genes (DEGs) within brain tissue during CSBI. Both Kyoto Encyclopedia of Genes and Genomes (KEGG) and Gene Ontology (GO) analyses were performed to determine signaling pathways associated with CSBI-induced DEGs. Agonists/antagonists were used to validate the pharmacodynamics of potential therapeutic targets. A combination of chronic restraint and cold water immersion successfully induced a rat model of CSBI, as indicated by various markers of brain injury and cell apoptosis that were verified via Nissl staining, Western blotting, and behavioral tests. RNA-seq analysis identified 1131 DEGs in CSBI rats. Of these DEGs, 553 genes were up-regulated and 778 genes were down-regulated. GO and KEGG pathway analyses revealed that significant DEGs were predominantly related to membrane-bound ion channels, among which the potassium channel function was found to be significantly affected. Pharmacological experiments revealed that retigabine, a voltage-gated potassium channel opener, demonstrated a protective effect in CSBI rats. Taken together, our findings suggest that potassium channel function is disrupted in CSBI, and that potassium channel regulators may function as anti-CSBI drugs. Chronic stress-induced brain injury (CSBI) is the organic damage of brain tissue caused by long-term psychological and environmental stress. However, there is no effective drug for the treatment of CSBI. The present study aimed to investigate possible mechanisms of CSBI and to explore related therapeutic targets. A rat model of CSBI was established by combining chronic restraint and cold water immersion. Our CSBI model was validated via Nissl staining, Western blotting, and behavioral tests. RNA sequencing (RNA-seq) was used to identify differentially expressed genes (DEGs) within brain tissue during CSBI. Both Kyoto Encyclopedia of Genes and Genomes (KEGG) and Gene Ontology (GO) analyses were performed to determine signaling pathways associated with CSBI-induced DEGs. Agonists/antagonists were used to validate the pharmacodynamics of potential therapeutic targets. A combination of chronic restraint and cold water immersion successfully induced a rat model of CSBI, as indicated by various markers of brain injury and cell apoptosis that were verified via Nissl staining, Western blotting, and behavioral tests. RNA-seq analysis identified 1131 DEGs in CSBI rats. Of these DEGs, 553 genes were up-regulated and 778 genes were down-regulated. GO and KEGG pathway analyses revealed that significant DEGs were predominantly related to membrane-bound ion channels, among which the potassium channel function was found to be significantly affected. Pharmacological experiments revealed that retigabine, a voltage-gated potassium channel opener, demonstrated a protective effect in CSBI rats. Taken together, our findings suggest that potassium channel function is disrupted in CSBI, and that potassium channel regulators may function as anti-CSBI drugs. Graphical Abstract Chronic stress-induced brain injury (CSBI) is the organic damage of brain tissue caused by long-term psychological and environmental stress. However, there is no effective drug for the treatment of CSBI. The present study aimed to investigate possible mechanisms of CSBI and to explore related therapeutic targets. A rat model of CSBI was established by combining chronic restraint and cold water immersion. Our CSBI model was validated via Nissl staining, Western blotting, and behavioral tests. RNA sequencing (RNA-seq) was used to identify differentially expressed genes (DEGs) within brain tissue during CSBI. Both Kyoto Encyclopedia of Genes and Genomes (KEGG) and Gene Ontology (GO) analyses were performed to determine signaling pathways associated with CSBI-induced DEGs. Agonists/antagonists were used to validate the pharmacodynamics of potential therapeutic targets. A combination of chronic restraint and cold water immersion successfully induced a rat model of CSBI, as indicated by various markers of brain injury and cell apoptosis that were verified via Nissl staining, Western blotting, and behavioral tests. RNA-seq analysis identified 1131 DEGs in CSBI rats. Of these DEGs, 553 genes were up-regulated and 778 genes were downregulated. GO and KEGG pathway analyses revealed that significant DEGs were predominantly related to membrane-bound ion channels, among which the potassium channel function was found to be significantly affected. Pharmacological experiments revealed that retigabine, a voltage-gated potassium channel opener, demonstrated a protective effect in CSBI rats. Taken together, our findings suggest that potassium channel function is disrupted in CSBI, and that potassium channel regulators may function as anti-CSBI drugs. |
| Author | Gao, Ruiping Wang, Qiyou Feng, Chuyu Qin, Cuiying Zhu, Shuguang Zhao, Chunhe He, Zhenfeng Qin, Changyun Ren, Jianhui Guo, Jiquan Zang, Linquan Wang, Zhanle |
| Author_xml | – sequence: 1 fullname: Ren, Jianhui organization: School of Pharmacy, Guangdong Pharmaceutical University – sequence: 2 fullname: Guo, Jiquan organization: Department of Respiratory, Guangdong Provincial People’s Hospital – sequence: 3 fullname: Zhu, Shuguang organization: Department of Cardiothoracic Surgery, First Affiliated Hospital of Guangdong Pharmaceutical College – sequence: 4 fullname: Wang, Qiyou organization: Orthopedics, Third Affiliated Hospital of Sun Yat-Sen University – sequence: 5 fullname: Gao, Ruiping organization: School of Clinical Medicine, First Affiliated Hospital of Guangdong Pharmaceutical College – sequence: 6 fullname: Zhao, Chunhe organization: School of Pharmacy, Guangdong Pharmaceutical University – sequence: 7 fullname: Feng, Chuyu organization: School of Pharmacy, Guangdong Pharmaceutical University – sequence: 8 fullname: Qin, Cuiying organization: School of Pharmacy, Guangdong Pharmaceutical University – sequence: 9 fullname: He, Zhenfeng organization: School of Pharmacy, Guangdong Pharmaceutical University – sequence: 10 fullname: Qin, Changyun organization: School of Pharmacy, Guangdong Pharmaceutical University – sequence: 11 fullname: Wang, Zhanle organization: School of Pharmacy, Guangdong Pharmaceutical University – sequence: 12 fullname: Zang, Linquan organization: School of Pharmacy, Guangdong Pharmaceutical University |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/33239494$$D View this record in MEDLINE/PubMed |
| BookMark | eNp1kU1vEzEQhi1URNPCkStaiQuXLeOPXe8eISolUiUQlLNlO7PEkWMH23vov8dp2iBV4jJjaZ6ZecfvBTkLMSAhbylcUSaGj2ZvrgyDFqAD8YIsKBey7RjtzsgCRjq0Pe2Gc3KR8xYAJDD-ipxzzvgoRrEg13cbbH5Ej02cmu-x6JzdvGuWGx0C-ty4UN8pBmebnyVhzu0qrGeL6-Zz0rW4Cts53b8mLyftM755zJfk15fru-XX9vbbzWr56ba1EqC0A6eiM0OHUz9Jy6WYKAM0nFvBQRpdK4PgONoJdc95D6Pgoh5kR22QSsMvyYfj3H2Kf2bMRe1ctui9DhjnrJjoRQ9d1_UVff8M3cY5haquUkNPpWQwVOrdIzWbHa7VPrmdTvfq6YMqwI-ATTHnhJOyrujiYij1fq8oqIMNqtqgqg3qwYba1T7rehr8P_7myFcNzmofg3cB_ym2WRoXfVQMGK09QgCriSug_VjDAFwe9I510vI4aZuL_o2nvToVZz0-7BVCsUM47T9V7UYnhYH_BS7XtNo |
| CitedBy_id | crossref_primary_10_1002_da_23289 crossref_primary_10_1152_jn_00045_2022 crossref_primary_10_1080_10253890_2022_2077099 crossref_primary_10_1002_ardp_202200473 crossref_primary_10_1128_msystems_01014_24 crossref_primary_10_3389_fphar_2021_777607 crossref_primary_10_3389_fcimb_2021_706849 |
| Cites_doi | 10.1038/tp.2017.161 10.1192/bjp.bp.110.080499 10.1038/s41598-019-53624-1 10.1016/j.pnpbp.2010.08.026 10.1001/jama.2018.7028 10.1111/j.1528-1167.2011.03365.x 10.1002/j.1460-2075.1996.tb00697.x 10.1007/s12576-009-0044-8 10.1091/mbc.E17-02-0120 10.1038/nrd2983 10.1046/j.1471-4159.2000.0740001.x 10.1046/j.1460-9568.2003.02513.x 10.1007/s12576-010-0119-6 10.1016/j.biopha.2018.12.141 10.1007/s004010050421 10.1038/nm.3589 10.1161/01.HYP.7.4.519 10.1016/j.brainres.2019.03.020 10.1073/pnas.1203930109 10.1002/brb3.1633 10.1016/0006-8993(92)91597-8 10.1016/j.expneurol.2012.03.012 10.1007/s00018-015-1948-5 10.1038/nrn2651 10.14814/phy2.13920 10.1098/rstb.2013.0094 10.1074/jbc.272.39.24371 10.1177/0271678X19857818 10.1016/j.taap.2020.114963 10.1016/j.brainresbull.2017.07.021 10.1016/j.dsx.2018.08.004 10.1016/j.biopsych.2010.02.008 10.1038/nrn2148 10.1073/pnas.1806392115 10.1176/jnp.10.2.230a 10.1152/ajpcell.1998.274.6.C1501 10.1006/meth.2001.1262 10.1038/nrcardio.2017.189 10.1016/0306-4522(88)90033-4 10.1038/35036198 10.1038/s41467-019-13639-8 10.1038/nrd2780 10.1186/s12964-018-0317-z |
| ContentType | Journal Article |
| Copyright | 2021 The Pharmaceutical Society of Japan Copyright Japan Science and Technology Agency 2021 |
| Copyright_xml | – notice: 2021 The Pharmaceutical Society of Japan – notice: Copyright Japan Science and Technology Agency 2021 |
| CorporateAuthor | aSchool of Pharmacy Guangdong Provincial People's Hospital dOrthopedics Guangdong Pharmaceutical University cDepartment of Cardiothoracic Surgery and (eSchool of Clinical Medicine bDepartment of Respiratory Third Affiliated Hospital of Sun Yat-Sen University First Affiliated Hospital of Guangdong Pharmaceutical College |
| CorporateAuthor_xml | – name: Guangdong Provincial People's Hospital – name: First Affiliated Hospital of Guangdong Pharmaceutical College – name: Third Affiliated Hospital of Sun Yat-Sen University – name: bDepartment of Respiratory – name: dOrthopedics – name: Guangdong Pharmaceutical University – name: aSchool of Pharmacy – name: cDepartment of Cardiothoracic Surgery – name: and (eSchool of Clinical Medicine |
| DBID | AAYXX CITATION NPM 7QP 7QR 7TK 7U9 8FD FR3 H94 P64 7X8 |
| DOI | 10.1248/bpb.b20-00504 |
| DatabaseName | CrossRef PubMed Calcium & Calcified Tissue Abstracts Chemoreception Abstracts Neurosciences Abstracts Virology and AIDS Abstracts Technology Research Database Engineering Research Database AIDS and Cancer Research Abstracts Biotechnology and BioEngineering Abstracts MEDLINE - Academic |
| DatabaseTitle | CrossRef PubMed Virology and AIDS Abstracts Technology Research Database AIDS and Cancer Research Abstracts Chemoreception Abstracts Engineering Research Database Calcium & Calcified Tissue Abstracts Neurosciences Abstracts Biotechnology and BioEngineering Abstracts MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic PubMed Virology and AIDS Abstracts |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Anatomy & Physiology Chemistry Pharmacy, Therapeutics, & Pharmacology |
| EISSN | 1347-5215 |
| EndPage | 180 |
| ExternalDocumentID | 33239494 10_1248_bpb_b20_00504 cs7biolo_2021_004402_003_0169_01803739499 article_bpb_44_2_44_b20_00504_article_char_en |
| Genre | Journal Article |
| GroupedDBID | --- 23N 2WC 5GY 6J9 ACGFO ACIWK ACPRK ADBBV AENEX AFFNX AFRAH ALMA_UNASSIGNED_HOLDINGS BAWUL BKOMP CS3 DIK DU5 E3Z EBS EJD F5P GX1 HH5 JMI JSF JSH KQ8 MOJWN OK1 P2P RJT RZJ TR2 XSB ABJNI AAYXX CITATION NPM 7QP 7QR 7TK 7U9 8FD FR3 H94 P64 7X8 |
| ID | FETCH-LOGICAL-c700t-83145b85ef6f7c374f120eb33c4307ba85e843e9cfea633609434134c9abe17b3 |
| ISSN | 0918-6158 1347-5215 |
| IngestDate | Thu Jul 10 17:38:24 EDT 2025 Mon Jun 30 09:51:45 EDT 2025 Thu Jan 02 22:58:28 EST 2025 Tue Jul 01 02:44:00 EDT 2025 Thu Apr 24 22:52:09 EDT 2025 Thu Jul 10 16:11:27 EDT 2025 Thu Aug 17 20:32:39 EDT 2023 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 2 |
| Keywords | potassium channel brain injury retigabine chronic stress RNA-sequencing (RNA-seq) bioinformatics |
| Language | English |
| LinkModel | OpenURL |
| MergedId | FETCHMERGED-LOGICAL-c700t-83145b85ef6f7c374f120eb33c4307ba85e843e9cfea633609434134c9abe17b3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
| OpenAccessLink | https://www.jstage.jst.go.jp/article/bpb/44/2/44_b20-00504/_article/-char/en |
| PMID | 33239494 |
| PQID | 2486177208 |
| PQPubID | 1966364 |
| PageCount | 12 |
| ParticipantIDs | proquest_miscellaneous_2464605556 proquest_journals_2486177208 pubmed_primary_33239494 crossref_citationtrail_10_1248_bpb_b20_00504 crossref_primary_10_1248_bpb_b20_00504 medicalonline_journals_cs7biolo_2021_004402_003_0169_01803739499 jstage_primary_article_bpb_44_2_44_b20_00504_article_char_en |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2021-02-01 |
| PublicationDateYYYYMMDD | 2021-02-01 |
| PublicationDate_xml | – month: 02 year: 2021 text: 2021-02-01 day: 01 |
| PublicationDecade | 2020 |
| PublicationPlace | Japan |
| PublicationPlace_xml | – name: Japan – name: Tokyo |
| PublicationTitle | Biological & pharmaceutical bulletin |
| PublicationTitleAlternate | Biol Pharm Bull |
| PublicationYear | 2021 |
| Publisher | The Pharmaceutical Society of Japan Pharmaceutical Society of Japan Japan Science and Technology Agency |
| Publisher_xml | – name: The Pharmaceutical Society of Japan – name: Pharmaceutical Society of Japan – name: Japan Science and Technology Agency |
| References | 4) Heidt T, Sager HB, Courties G, Dutta P, Iwamoto Y, Zaltsman A, von Zur Muhlen C, Bode C, Fricchione GL, Denninger J, Lin CP, Vinegoni C, Libby P, Swirski FK, Weissleder R, Nahrendorf M. Chronic variable stress activates hematopoietic stem cells. Nat. Med., 20, 754–758 (2014). 34) Bean BP. The action potential in mammalian central neurons. Nat. Rev. Neurosci., 8, 451–465 (2007). 44) Ru Q, Li WL, Xiong Q, Chen L, Tian X, Li CY. Voltage-gated potassium channel blocker 4-aminopyridine induces glioma cell apoptosis by reducing expression of microRNA-10b-5p. Mol. Biol. Cell, 29, 1125–1136 (2018). 15) Zhang YY, Zhu WX, Cao GH, Cui XY, Ai HB. c-Fos expression in the supraoptic nucleus is the most intense during different durations of restraint water-immersion stress in the rat. J. Physiol. Sci., 59, 367–375 (2009). 28) Wang M, Bi Y, Zeng S, Liu Y, Shao M, Liu K, Deng Y, Wen G, Sun X, Zeng P, Jing L, Lv Z. Modified Xiaoyao San ameliorates depressive-like behaviors by triggering autophagosome formation to alleviate neuronal apoptosis. Biomed. Pharmacother., 111, 1057–1065 (2019). 49) Li GB, Liu JY, Feng XM, Zhang BL, Zhang RS. Retigabine attenuates focal cerebral ischemic injury through inhibiting mitochondria-dependent apoptotic pathway. Eur. Rev. Med. Pharmacol. Sci., 22, 5018–5023 (2018). 52) Rosenkranz JA, Venheim ER, Padival M. Chronic stress causes amygdala hyperexcitability in rodents. Biol. Psychiatry, 67, 1128–1136 (2010). 19) Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2−ΔΔCt method. Methods, 25, 402–408 (2001). 1) Selye H. A syndrome produced by diverse nocuous agents. J. Neuropsychiatry Clin. Neurosci., 10, 230a–231 (1998). 12) Watanabe Y, Gould E, Mcewen BS. Stress induces atrophy of apical dendrites of hippocampal CA3 pyramidal neurons. Brain Res., 588, 341–345 (1992). 2) Kim JS, Han SY, Iremonger KJ. Stress experience and hormone feedback tune distinct components of hypothalamic CRH neuron activity. Nat. Commun., 10, 5696 (2019). 45) Bocksteins E, Snyders DJ. Electrically silent Kv subunits: their molecular and functional characteristics. Physiology, 27, 73–84 (2012). 36) Saha RN, Dudek SM. Action potentials: to the nucleus and beyond. Exp. Biol. Med. (Maywood), 233, 385–393 (2008). 26) Hicks R, Soares H, Smith D, McIntosh T. Temporal and spatial characterization of neuronal injury following lateral fluid-percussion brain injury in the rat. Acta Neuropathol., 91, 236–246 (1996). 5) Yaribeygi H, Panahi Y, Sahraei H, Johnston TP, Sahebkar A. The impact of stress on body function: A review. EXCLI J., 16, 1057–1072 (2017). 6) Kessler RC, McLaughlin KA, Green JG, et al. Childhood adversities and adult psychopathology in the WHO World Mental Health Surveys. Br. J. Psychiatry, 197, 378–385 (2010). 31) Meyer DL, Davies DR, Barr JL, Manzerra P, Forster GL. Mild traumatic brain injury in the rat alters neuronal number in the limbic system and increases conditioned fear and anxiety-like behaviors. Exp. Neurol., 235, 574–587 (2012). 35) Simms BA, Zamponi GW. Neuronal voltage-gated calcium channels: structure, function, and dysfunction. Neuron, 82, 24–45 (2014). 42) Urrego D, Tomczak AP, Zahed F, Stühmer W, Pardo LA. Potassium channels in cell cycle and cell proliferation. Philos. Trans. R. Soc.Lond. B Biol. Sci., 369, 20130094 (2014). 20) Wang Y, Jiang H, Meng H, Lu J, Li J, Zhang X, Yang X, Zhao B, Sun Y, Bao T. Genome-wide transcriptome analysis of hippocampus in rats indicated that the TLR/NLR signaling pathway was involved in the pathogenesis of depressive disorder induced by chronic restraint stress. Brain Res. Bull., 134, 195–204 (2017). 27) Sastry PS, Rao KS. Apoptosis and the nervous system. J. Neurochem., 74, 1–20 (2000). 25) Feng Z, Liu L, Zhang C, Zheng T, Wang J, Lin M, Zhao Y, Wang X, Levine AJ, Hu W. Chronic restraint stress attenuates p53 function and promotes tumorigenesis. Proc. Natl. Acad. Sci. U.S.A., 109, 7013–7018 (2012). 30) Zhao Y, Shang P, Wang M, Xie M, Liu J. Neuroprotective effects of fluoxetine against chronic stress-induced neural inflammation and apoptosis: involvement of the p38 activity. Front. Physiol., 11, 351 (2020). 50) Gore A, Neufeld-Cohen A, Egoz I, Baranes S, Gez R, Grauer E, Chapman S, Lazar S. Efficacy of retigabine in ameliorating the brain insult following sarin exposure in the rat. Toxicol. Appl. Pharmacol., 395, 114963 (2020). 33) Hille B. Ionic channels of excitable membranes. Sinauer, Sunderland, MA (2001). 18) Cordero AS, Bastos AS, Fornaguera J, Brebes JC. Behavioural characterisation of chronic unpredictable stress based on ethologically relevant paradigms in rats. Sci. Rep., 9, 17403 (2019). 16) Zhao DQ, Lu CL, Ai HB. The role of catecholaminergic neurons in the hypothalamus and medullary visceral zone in response to restraint water-immersion stress in rats. J. Physiol. Sci., 61, 37–45 (2011). 39) Rudy B. Diversity and ubiquity of K channels. Neuroscience, 25, 729–749 (1988). 32) Wang J, Li P, Qin T, Sun D, Zhao X, Zhang B. Protective effect of epigallocatechin-3-gallate against neuroinflammation and anxiety-like behavior in a rat model of myocardial infarction. Brain Behav., 10, e01633 (2020). 40) Jentsch TJ. Neuronal KCNQ potassium channels: physiology and role in disease. Nat. Rev. Neurosci., 1, 21–30 (2000). 17) Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Stat. Soc. Series B Stat. Methodol., 57, 289–300 (1995). 22) Kramer JW, Post MA, Brown AM, Kirsch GE. Modulation of potassium channel gating by co-expression of Kv2.1 with regulatory Kv5.1 or Kv6.1 alpha-subunits. Am. J. Physiol., 274, C1501–C1510 (1998). 37) Verkman AS, Galietta LJ. Chloride channels as drug targets. Nat. Rev. Drug Discov., 8, 153–171 (2009). 38) Kuang Q, Purhonen P, Hebert H. Structure of potassium channels. Cell. Mol. Life Sci., 72, 3677–3693 (2015). 10) Kivimäki M, Steptoe A. Effects of stress on the development and progression of cardiovascular disease. Nat. Rev. Cardiol., 15, 215–229 (2018). 51) Sharp BM. Basolateral amygdala and stress-induced hyperexcitability affect motivated behaviors and addiction. Transl. Psychiatry, 7, e1194 (2017). 46) Wulff H, Castle NA, Pardo LA. Voltage-gated potassium channels as therapeutic targs. Nat. Rev. Drug Discov., 8, 982–1001 (2009). 43) Lowinus T, Heidel FH, Bose T, Nimmagadda SC, Schnöder T, Cammann C, Schmitz I, Seifert U, Fischer T, Schraven B, Bommhardt U. Memantine potentiates cytarabine-induced cell death of acute leukemia correlating with inhibition of Kv1.3 potassium channels, AKT and ERK1/2 signaling. Cell Commun. Signal., 17, 5 (2019). 29) Kubera M, Obuchowicz E, Goehler L, Brzeszcz J, Maes M. In animal models, psychosocial stress-induced (neuro)inflammation, apoptosis and reduced neurogenesis are associated to the onset of depression. Prog. Neuropsychopharmacol. Biol. Psychiatry, 35, 744–759 (2011). 7) Madhu SV, Siddiqui A, Desai NG, Sharma SB, Bansal AK. Chronic stress, sense of coherence and risk of type 2 diabetes mellitus. Diabetes Metab. Syndr., 13, 18–23 (2019). 48) Vigil FA, Bozdemir E, Bugay V, Chun SH, Hobbs M, Sanchez I, Hastings SD, Veraza RJ, Holstein DM, Sprague SMM, Carver C, Cavazos JE, Brenner R, Lechleiter JD, Shapiro MS. Prevention of brain damage after traumatic brain injury by pharmacological enhancement of KCNQ (Kv7, “M-type”) K+ currents in neurons. J. Cereb. Blood Flow Metab., 40, 1256–1273 (2020). 13) Banagozar Mohammadi A, Torbati M, Farajdokht F, Sadigh-Eteghad S, Fazljou SMB, Vatandoust SM, Golzari SEJ, Mahmoudi J. Sericin alleviates restraint stress induced depressive- and anxiety-like behaviors via modulation of oxidative stress, neuroinflammation and apoptosis in the prefrontal cortex and hippocampus. Brain Res., 1715, 47–56 (2019). 14) Roozendaal B, McEwen BS, Chattarji S. Stress, memory and the amygdala. Nat. Rev. Neurosci., 10, 423–433 (2009). 11) Pham K, Nacher J, Hof PR, McEwen BS. Repeated restraint stress suppresses neurogenesis and induces biphasic PSA-NCAM expression in the adult rat dentate gyrus. Eur. J. Neurosci., 17, 879–886 (2003). 47) Gunthorpe MJ, Large CH, Sankar R. The mechanism of action of retigabine (ezogabine), a first-in-class K+ channel opener for the treatment of epilepsy. Epilepsia, 53, 412–424 (2012). 23) Salinas M, Duprat F, Heurteaux C, Hugnot JP, Lazdunski M. New modulatory alpha subunits for mammalian Shab K+ channels. J. Biol. Chem., 272, 24371–24379 (1997). 9) Song H, Fang F, Tomasson G, Arnberg FK, Mataix-Cols D, Fernández de la Cruz L, Almqvist C, Fall K, Valdimarsdóttir UA. Association of stress-related disorders with subsequent autoimmune disease. JAMA, 319, 2388–2400 (2018). 3) Sunwoo SH, Lee JS, Bae S, Shin YJ, Kim CS, Joo SY, Choi HS, Suh M, Kim SW, Choi YJ, Kim TI. Chronic and acute stress monitoring by electrophysiological signals from adrenal gland. Proc. Natl. Acad. Sci. U.S.A., 116, 1146–1151 (2019). 24) de Jong IEM, Jepps TA. Impaired Kv7 channel function in cerebral arteries of a tauopathy mouse model (rTg4510). Physiol. Rep., 6, e13920 (2018). 21) Hugnot JP, Salinas M, Lesage F, Guillemare E, de Weille J, Heurteaux C, Mattéi MG, Lazdunski M. Kv8.1, a new neuronal potassium channel subunit with specific inhibitory properties towards Shab and Shaw channels. EMBO J., 15, 3322–3331 (1996). 41) Litt M, Kramer P, Browne D, Gancher S, Brunt ER, Root D, Phromchotikul T, Dubay CJ, Nutt J. A gene for episodic ataxia/myokymia maps to chromosome 12p13. Am. J. Hum. Genet., 55, 702–709 (1994). 8) Chan TC, Wall RA, Sutter MC. Chronic ethanol consumption, stress, and hypertension. Hypertension, 7, 519–524 (1985). 44 45 46 47 48 49 50 51 52 10 11 12 13 14 15 16 17 18 19 1 2 3 4 5 6 7 8 9 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 |
| References_xml | – reference: 28) Wang M, Bi Y, Zeng S, Liu Y, Shao M, Liu K, Deng Y, Wen G, Sun X, Zeng P, Jing L, Lv Z. Modified Xiaoyao San ameliorates depressive-like behaviors by triggering autophagosome formation to alleviate neuronal apoptosis. Biomed. Pharmacother., 111, 1057–1065 (2019). – reference: 17) Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Stat. Soc. Series B Stat. Methodol., 57, 289–300 (1995). – reference: 7) Madhu SV, Siddiqui A, Desai NG, Sharma SB, Bansal AK. Chronic stress, sense of coherence and risk of type 2 diabetes mellitus. Diabetes Metab. Syndr., 13, 18–23 (2019). – reference: 16) Zhao DQ, Lu CL, Ai HB. The role of catecholaminergic neurons in the hypothalamus and medullary visceral zone in response to restraint water-immersion stress in rats. J. Physiol. Sci., 61, 37–45 (2011). – reference: 42) Urrego D, Tomczak AP, Zahed F, Stühmer W, Pardo LA. Potassium channels in cell cycle and cell proliferation. Philos. Trans. R. Soc.Lond. B Biol. Sci., 369, 20130094 (2014). – reference: 37) Verkman AS, Galietta LJ. Chloride channels as drug targets. Nat. Rev. Drug Discov., 8, 153–171 (2009). – reference: 5) Yaribeygi H, Panahi Y, Sahraei H, Johnston TP, Sahebkar A. The impact of stress on body function: A review. EXCLI J., 16, 1057–1072 (2017). – reference: 45) Bocksteins E, Snyders DJ. Electrically silent Kv subunits: their molecular and functional characteristics. Physiology, 27, 73–84 (2012). – reference: 27) Sastry PS, Rao KS. Apoptosis and the nervous system. J. Neurochem., 74, 1–20 (2000). – reference: 22) Kramer JW, Post MA, Brown AM, Kirsch GE. Modulation of potassium channel gating by co-expression of Kv2.1 with regulatory Kv5.1 or Kv6.1 alpha-subunits. Am. J. Physiol., 274, C1501–C1510 (1998). – reference: 6) Kessler RC, McLaughlin KA, Green JG, et al. Childhood adversities and adult psychopathology in the WHO World Mental Health Surveys. Br. J. Psychiatry, 197, 378–385 (2010). – reference: 52) Rosenkranz JA, Venheim ER, Padival M. Chronic stress causes amygdala hyperexcitability in rodents. Biol. Psychiatry, 67, 1128–1136 (2010). – reference: 38) Kuang Q, Purhonen P, Hebert H. Structure of potassium channels. Cell. Mol. Life Sci., 72, 3677–3693 (2015). – reference: 43) Lowinus T, Heidel FH, Bose T, Nimmagadda SC, Schnöder T, Cammann C, Schmitz I, Seifert U, Fischer T, Schraven B, Bommhardt U. Memantine potentiates cytarabine-induced cell death of acute leukemia correlating with inhibition of Kv1.3 potassium channels, AKT and ERK1/2 signaling. Cell Commun. Signal., 17, 5 (2019). – reference: 11) Pham K, Nacher J, Hof PR, McEwen BS. Repeated restraint stress suppresses neurogenesis and induces biphasic PSA-NCAM expression in the adult rat dentate gyrus. Eur. J. Neurosci., 17, 879–886 (2003). – reference: 50) Gore A, Neufeld-Cohen A, Egoz I, Baranes S, Gez R, Grauer E, Chapman S, Lazar S. Efficacy of retigabine in ameliorating the brain insult following sarin exposure in the rat. Toxicol. Appl. Pharmacol., 395, 114963 (2020). – reference: 2) Kim JS, Han SY, Iremonger KJ. Stress experience and hormone feedback tune distinct components of hypothalamic CRH neuron activity. Nat. Commun., 10, 5696 (2019). – reference: 15) Zhang YY, Zhu WX, Cao GH, Cui XY, Ai HB. c-Fos expression in the supraoptic nucleus is the most intense during different durations of restraint water-immersion stress in the rat. J. Physiol. Sci., 59, 367–375 (2009). – reference: 48) Vigil FA, Bozdemir E, Bugay V, Chun SH, Hobbs M, Sanchez I, Hastings SD, Veraza RJ, Holstein DM, Sprague SMM, Carver C, Cavazos JE, Brenner R, Lechleiter JD, Shapiro MS. Prevention of brain damage after traumatic brain injury by pharmacological enhancement of KCNQ (Kv7, “M-type”) K+ currents in neurons. J. Cereb. Blood Flow Metab., 40, 1256–1273 (2020). – reference: 33) Hille B. Ionic channels of excitable membranes. Sinauer, Sunderland, MA (2001). – reference: 12) Watanabe Y, Gould E, Mcewen BS. Stress induces atrophy of apical dendrites of hippocampal CA3 pyramidal neurons. Brain Res., 588, 341–345 (1992). – reference: 29) Kubera M, Obuchowicz E, Goehler L, Brzeszcz J, Maes M. In animal models, psychosocial stress-induced (neuro)inflammation, apoptosis and reduced neurogenesis are associated to the onset of depression. Prog. Neuropsychopharmacol. Biol. Psychiatry, 35, 744–759 (2011). – reference: 24) de Jong IEM, Jepps TA. Impaired Kv7 channel function in cerebral arteries of a tauopathy mouse model (rTg4510). Physiol. Rep., 6, e13920 (2018). – reference: 44) Ru Q, Li WL, Xiong Q, Chen L, Tian X, Li CY. Voltage-gated potassium channel blocker 4-aminopyridine induces glioma cell apoptosis by reducing expression of microRNA-10b-5p. Mol. Biol. Cell, 29, 1125–1136 (2018). – reference: 34) Bean BP. The action potential in mammalian central neurons. Nat. Rev. Neurosci., 8, 451–465 (2007). – reference: 41) Litt M, Kramer P, Browne D, Gancher S, Brunt ER, Root D, Phromchotikul T, Dubay CJ, Nutt J. A gene for episodic ataxia/myokymia maps to chromosome 12p13. Am. J. Hum. Genet., 55, 702–709 (1994). – reference: 39) Rudy B. Diversity and ubiquity of K channels. Neuroscience, 25, 729–749 (1988). – reference: 40) Jentsch TJ. Neuronal KCNQ potassium channels: physiology and role in disease. Nat. Rev. Neurosci., 1, 21–30 (2000). – reference: 30) Zhao Y, Shang P, Wang M, Xie M, Liu J. Neuroprotective effects of fluoxetine against chronic stress-induced neural inflammation and apoptosis: involvement of the p38 activity. Front. Physiol., 11, 351 (2020). – reference: 35) Simms BA, Zamponi GW. Neuronal voltage-gated calcium channels: structure, function, and dysfunction. Neuron, 82, 24–45 (2014). – reference: 9) Song H, Fang F, Tomasson G, Arnberg FK, Mataix-Cols D, Fernández de la Cruz L, Almqvist C, Fall K, Valdimarsdóttir UA. Association of stress-related disorders with subsequent autoimmune disease. JAMA, 319, 2388–2400 (2018). – reference: 10) Kivimäki M, Steptoe A. Effects of stress on the development and progression of cardiovascular disease. Nat. Rev. Cardiol., 15, 215–229 (2018). – reference: 1) Selye H. A syndrome produced by diverse nocuous agents. J. Neuropsychiatry Clin. Neurosci., 10, 230a–231 (1998). – reference: 31) Meyer DL, Davies DR, Barr JL, Manzerra P, Forster GL. Mild traumatic brain injury in the rat alters neuronal number in the limbic system and increases conditioned fear and anxiety-like behaviors. Exp. Neurol., 235, 574–587 (2012). – reference: 49) Li GB, Liu JY, Feng XM, Zhang BL, Zhang RS. Retigabine attenuates focal cerebral ischemic injury through inhibiting mitochondria-dependent apoptotic pathway. Eur. Rev. Med. Pharmacol. Sci., 22, 5018–5023 (2018). – reference: 3) Sunwoo SH, Lee JS, Bae S, Shin YJ, Kim CS, Joo SY, Choi HS, Suh M, Kim SW, Choi YJ, Kim TI. Chronic and acute stress monitoring by electrophysiological signals from adrenal gland. Proc. Natl. Acad. Sci. U.S.A., 116, 1146–1151 (2019). – reference: 25) Feng Z, Liu L, Zhang C, Zheng T, Wang J, Lin M, Zhao Y, Wang X, Levine AJ, Hu W. Chronic restraint stress attenuates p53 function and promotes tumorigenesis. Proc. Natl. Acad. Sci. U.S.A., 109, 7013–7018 (2012). – reference: 26) Hicks R, Soares H, Smith D, McIntosh T. Temporal and spatial characterization of neuronal injury following lateral fluid-percussion brain injury in the rat. Acta Neuropathol., 91, 236–246 (1996). – reference: 36) Saha RN, Dudek SM. Action potentials: to the nucleus and beyond. Exp. Biol. Med. (Maywood), 233, 385–393 (2008). – reference: 18) Cordero AS, Bastos AS, Fornaguera J, Brebes JC. Behavioural characterisation of chronic unpredictable stress based on ethologically relevant paradigms in rats. Sci. Rep., 9, 17403 (2019). – reference: 19) Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2−ΔΔCt method. Methods, 25, 402–408 (2001). – reference: 23) Salinas M, Duprat F, Heurteaux C, Hugnot JP, Lazdunski M. New modulatory alpha subunits for mammalian Shab K+ channels. J. Biol. Chem., 272, 24371–24379 (1997). – reference: 4) Heidt T, Sager HB, Courties G, Dutta P, Iwamoto Y, Zaltsman A, von Zur Muhlen C, Bode C, Fricchione GL, Denninger J, Lin CP, Vinegoni C, Libby P, Swirski FK, Weissleder R, Nahrendorf M. Chronic variable stress activates hematopoietic stem cells. Nat. Med., 20, 754–758 (2014). – reference: 20) Wang Y, Jiang H, Meng H, Lu J, Li J, Zhang X, Yang X, Zhao B, Sun Y, Bao T. Genome-wide transcriptome analysis of hippocampus in rats indicated that the TLR/NLR signaling pathway was involved in the pathogenesis of depressive disorder induced by chronic restraint stress. Brain Res. Bull., 134, 195–204 (2017). – reference: 21) Hugnot JP, Salinas M, Lesage F, Guillemare E, de Weille J, Heurteaux C, Mattéi MG, Lazdunski M. Kv8.1, a new neuronal potassium channel subunit with specific inhibitory properties towards Shab and Shaw channels. EMBO J., 15, 3322–3331 (1996). – reference: 46) Wulff H, Castle NA, Pardo LA. Voltage-gated potassium channels as therapeutic targs. Nat. Rev. Drug Discov., 8, 982–1001 (2009). – reference: 8) Chan TC, Wall RA, Sutter MC. Chronic ethanol consumption, stress, and hypertension. Hypertension, 7, 519–524 (1985). – reference: 14) Roozendaal B, McEwen BS, Chattarji S. Stress, memory and the amygdala. Nat. Rev. Neurosci., 10, 423–433 (2009). – reference: 47) Gunthorpe MJ, Large CH, Sankar R. The mechanism of action of retigabine (ezogabine), a first-in-class K+ channel opener for the treatment of epilepsy. Epilepsia, 53, 412–424 (2012). – reference: 51) Sharp BM. Basolateral amygdala and stress-induced hyperexcitability affect motivated behaviors and addiction. Transl. Psychiatry, 7, e1194 (2017). – reference: 13) Banagozar Mohammadi A, Torbati M, Farajdokht F, Sadigh-Eteghad S, Fazljou SMB, Vatandoust SM, Golzari SEJ, Mahmoudi J. Sericin alleviates restraint stress induced depressive- and anxiety-like behaviors via modulation of oxidative stress, neuroinflammation and apoptosis in the prefrontal cortex and hippocampus. Brain Res., 1715, 47–56 (2019). – reference: 32) Wang J, Li P, Qin T, Sun D, Zhao X, Zhang B. Protective effect of epigallocatechin-3-gallate against neuroinflammation and anxiety-like behavior in a rat model of myocardial infarction. Brain Behav., 10, e01633 (2020). – ident: 51 doi: 10.1038/tp.2017.161 – ident: 6 doi: 10.1192/bjp.bp.110.080499 – ident: 18 doi: 10.1038/s41598-019-53624-1 – ident: 29 doi: 10.1016/j.pnpbp.2010.08.026 – ident: 35 – ident: 9 doi: 10.1001/jama.2018.7028 – ident: 47 doi: 10.1111/j.1528-1167.2011.03365.x – ident: 21 doi: 10.1002/j.1460-2075.1996.tb00697.x – ident: 15 doi: 10.1007/s12576-009-0044-8 – ident: 49 – ident: 44 doi: 10.1091/mbc.E17-02-0120 – ident: 45 – ident: 41 – ident: 46 doi: 10.1038/nrd2983 – ident: 17 – ident: 27 doi: 10.1046/j.1471-4159.2000.0740001.x – ident: 11 doi: 10.1046/j.1460-9568.2003.02513.x – ident: 5 – ident: 16 doi: 10.1007/s12576-010-0119-6 – ident: 28 doi: 10.1016/j.biopha.2018.12.141 – ident: 26 doi: 10.1007/s004010050421 – ident: 30 – ident: 4 doi: 10.1038/nm.3589 – ident: 8 doi: 10.1161/01.HYP.7.4.519 – ident: 13 doi: 10.1016/j.brainres.2019.03.020 – ident: 25 doi: 10.1073/pnas.1203930109 – ident: 32 doi: 10.1002/brb3.1633 – ident: 12 doi: 10.1016/0006-8993(92)91597-8 – ident: 31 doi: 10.1016/j.expneurol.2012.03.012 – ident: 33 – ident: 38 doi: 10.1007/s00018-015-1948-5 – ident: 14 doi: 10.1038/nrn2651 – ident: 24 doi: 10.14814/phy2.13920 – ident: 42 doi: 10.1098/rstb.2013.0094 – ident: 23 doi: 10.1074/jbc.272.39.24371 – ident: 48 doi: 10.1177/0271678X19857818 – ident: 50 doi: 10.1016/j.taap.2020.114963 – ident: 20 doi: 10.1016/j.brainresbull.2017.07.021 – ident: 7 doi: 10.1016/j.dsx.2018.08.004 – ident: 52 doi: 10.1016/j.biopsych.2010.02.008 – ident: 34 doi: 10.1038/nrn2148 – ident: 3 doi: 10.1073/pnas.1806392115 – ident: 1 doi: 10.1176/jnp.10.2.230a – ident: 22 doi: 10.1152/ajpcell.1998.274.6.C1501 – ident: 19 doi: 10.1006/meth.2001.1262 – ident: 36 – ident: 10 doi: 10.1038/nrcardio.2017.189 – ident: 39 doi: 10.1016/0306-4522(88)90033-4 – ident: 40 doi: 10.1038/35036198 – ident: 2 doi: 10.1038/s41467-019-13639-8 – ident: 37 doi: 10.1038/nrd2780 – ident: 43 doi: 10.1186/s12964-018-0317-z |
| SSID | ssj0007023 ssib058492369 ssib023156946 ssib002483627 ssib002822050 ssib017383521 |
| Score | 2.3501432 |
| Snippet | Chronic stress-induced brain injury (CSBI) is the organic damage of brain tissue caused by long-term psychological and environmental stress. However, there is... |
| SourceID | proquest pubmed crossref medicalonline jstage |
| SourceType | Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 169 |
| SubjectTerms | Antagonists Apoptosis bioinformatics Brain injury chronic stress Drug development Environmental stress Genomes Immersion Pharmacodynamics Potassium potassium channel Potassium channels Potassium channels (voltage-gated) retigabine Ribonucleic acid RNA RNA-sequencing (RNA-seq) Therapeutic applications Traumatic brain injury Western blotting |
| Title | The Role of Potassium Channels in Chronic Stress-Induced Brain Injury |
| URI | https://www.jstage.jst.go.jp/article/bpb/44/2/44_b20-00504/_article/-char/en http://mol.medicalonline.jp/library/journal/download?GoodsID=cs7biolo/2021/004402/003&name=0169-0180e https://www.ncbi.nlm.nih.gov/pubmed/33239494 https://www.proquest.com/docview/2486177208 https://www.proquest.com/docview/2464605556 |
| Volume | 44 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| ispartofPNX | Biological and Pharmaceutical Bulletin, 2021/02/01, Vol.44(2), pp.169-180 |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3dixMxEA96Cgoi2vOjekoE6YvXXjfJfhR8sB49DjnOU1oovoRNmr32sNtqdx_qX-9Msh9d9ER9WZZNGrY7v0wymZnfEPKaKaUEFjRRcQwGiqfgzk90lxkTgU4OMLkToy3Og9OJ-DD1p7W7wGaXZKqnf_w2r-R_pArPQK6YJfsPkq0GhQdwD_KFK0gYrn8t489FeODFKoN98CJf2oSBFJY8m9DnuG-t83mz6WKhDnT4v8fCEKAbrvJmRrSrTGnlhpBYzxsH3mqXqhudNEViByBsni-qSJ7cOXMW3_IaeV_muT1nneeX8PSyPsZ3qubTYrvKdw8gmFfGLJeLAyzqtSbC0_7aKfBmaBNId08dvQisVcfW3jNO53IRgj3ssjpLpexIIQvwsR0N67nKLr9ofiYwm0GtVU8xzJX3XVXjJsP2-Ud5Mjk7k-PRdHyT3GJgWjCrzGuTKezbkoDVixa8rDD8UWPwxj7m9hVs5ZGj4d7Sudcczcn1VovdvYwfkPuF2UGHDkMPyQ2Ttsj-MI2z1XJLO9QGAtuP2SJ3jssigC3SuXAQ2B7ScZ2ptzm0P6lIz7f7ZATNFLFIVwmtsEhLLNJFSgss0iYWqcUidVh8RCYno_Hxabco0dHVYb-fdSPuCV9FvkmCJNQ8FInH-kZxrgUsHiqGlkhwM9CJiQPOA4xjhW2T0INYGS9U_DHZS1epeUpo7IuZVizmAkn1lFHCHyiPaz1jwcCf6TY5LD-41AV_PZZR-SrRjgX5SJCPBPlIK5826VTd14645bqOb530qm7FfLbdhJAML1X3qhWzIkEJtcm7hsxloR82Um9CS6QmcdJIW9udIRWvRAIkicR5POTIDdUmByVM6l_De4JxEbJ-1CavqmaQPjr04tSscuwTYFiD7wdt8sTBq_oTnDMcXDz78-DPyd16Th-Qvex7bl7ANjtTL-28-AnCxNJU |
| linkProvider | ABC ChemistRy |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+Role+of+Potassium+Channels+in+Chronic+Stress-Induced+Brain+Injury&rft.jtitle=Biological+%26+pharmaceutical+bulletin&rft.au=Ren%2C+Jianhui&rft.au=Guo%2C+Jiquan&rft.au=Zhu%2C+Shuguang&rft.au=Wang%2C+Qiyou&rft.date=2021-02-01&rft.pub=Japan+Science+and+Technology+Agency&rft.issn=0918-6158&rft.eissn=1347-5215&rft.volume=44&rft.issue=2&rft.spage=169&rft_id=info:doi/10.1248%2Fbpb.b20-00504&rft.externalDBID=NO_FULL_TEXT |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0918-6158&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0918-6158&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0918-6158&client=summon |